S. Roche

526 total citations
32 papers, 366 citations indexed

About

S. Roche is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Surgery. According to data from OpenAlex, S. Roche has authored 32 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pulmonary and Respiratory Medicine, 12 papers in Rheumatology and 5 papers in Surgery. Recurrent topics in S. Roche's work include Prostate Cancer Diagnosis and Treatment (16 papers), Prostate Cancer Treatment and Research (11 papers) and Urologic and reproductive health conditions (8 papers). S. Roche is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (16 papers), Prostate Cancer Treatment and Research (11 papers) and Urologic and reproductive health conditions (8 papers). S. Roche collaborates with scholars based in Spain, United Kingdom and France. S. Roche's co-authors include Philippe Cluzel, E. Mourgeon, J.D. Law-Koune, Louis Puybasset, Qin Lü, C. Devilliers, Jean‐Jacques Rouby, A. Celma, Juan Moróte and Jacques Planas and has published in prestigious journals such as Journal of Clinical Oncology, Neurology and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

S. Roche

28 papers receiving 346 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Roche Spain 10 225 90 85 60 53 32 366
Xiaoye Lu China 11 104 0.5× 162 1.8× 79 0.9× 42 0.7× 91 1.7× 22 419
H. Erhan Dincer United States 10 156 0.7× 29 0.3× 41 0.5× 8 0.1× 13 0.2× 23 421
Hideyuki Maeda Japan 10 149 0.7× 30 0.3× 21 0.2× 10 0.2× 5 0.1× 42 340
Stanley J. Antolak United States 8 61 0.3× 64 0.7× 43 0.5× 14 0.2× 5 0.1× 21 340
Takahiro Maeda Japan 12 58 0.3× 123 1.4× 18 0.2× 6 0.1× 11 0.2× 51 354
Munir Nashashibi Israel 7 67 0.3× 59 0.7× 15 0.2× 9 0.1× 7 0.1× 15 280
Daniel Char United States 10 187 0.8× 18 0.2× 6 0.1× 97 1.6× 11 0.2× 14 415
Shaan Chugh Canada 6 107 0.5× 18 0.2× 33 0.4× 8 0.1× 20 0.4× 11 432
Domenico Mancuso Italy 13 184 0.8× 17 0.2× 21 0.2× 14 0.2× 9 0.2× 23 442
Pierre Filhine-Trésarrieu France 7 29 0.1× 67 0.7× 27 0.3× 47 0.8× 10 0.2× 9 230

Countries citing papers authored by S. Roche

Since Specialization
Citations

This map shows the geographic impact of S. Roche's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Roche with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Roche more than expected).

Fields of papers citing papers by S. Roche

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Roche. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Roche. The network helps show where S. Roche may publish in the future.

Co-authorship network of co-authors of S. Roche

This figure shows the co-authorship network connecting the top 25 collaborators of S. Roche. A scholar is included among the top collaborators of S. Roche based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Roche. S. Roche is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Moróte, Juan, Lucas Regis, A. Celma, et al.. (2022). Who with suspected prostate cancer can benefit from Proclarix after multiparametric magnetic resonance imaging?. The International Journal of Biological Markers. 37(2). 218–223. 3 indexed citations
2.
Moróte, Juan, A. Celma, Lucas Regis, et al.. (2022). The Efficacy of Proclarix to Select Appropriate Candidates for Magnetic Resonance Imaging and Derived Prostate Biopsies in Men with Suspected Prostate Cancer. The World Journal of Men s Health. 40(2). 270–270. 9 indexed citations
3.
4.
Moróte, Juan, A. Celma, S. Roche, et al.. (2021). The current recommendation for the management of isolated high‐grade prostatic intraepithelial neoplasia. British Journal of Urology. 129(5). 627–633. 7 indexed citations
5.
Celma, A., Lucas Regis, Jacques Planas, et al.. (2021). The current value of histological findings in negative prostate biopsies to predict the future risk of clinically significant prostate cancer. Actas Urológicas Españolas (English Edition). 45(6). 447–454.
6.
Moróte, Juan, A. Celma, José Fernando Jiménez Díaz, et al.. (2020). Prostatic-specific antigen density behavior according to multiparametric magnetic resonance imaging result. Urologic Oncology Seminars and Original Investigations. 38(5). 410–417. 11 indexed citations
7.
Moróte, Juan, Ángel Borque‐Fernando, Luis Esteban, et al.. (2020). Prediction of clinically significant prostate cancer after negative prostate biopsy: The current value of microscopic findings. Urologic Oncology Seminars and Original Investigations. 39(7). 432.e11–432.e19. 4 indexed citations
8.
Borque‐Fernando, Ángel, Luis Esteban, A. Celma, et al.. (2019). How to implement magnetic resonance imaging before prostate biopsy in clinical practice: nomograms for saving biopsies. World Journal of Urology. 38(6). 1481–1491. 8 indexed citations
9.
Regis, Lucas, A. Celma, Jacques Planas, et al.. (2019). The role of negative magnetic resonance imaging: can we safely avoid biopsy in P.I.-R.A.D.S. 2 as in P.I.-R.A.D.S. 1?. Scandinavian Journal of Urology. 53(1). 21–25. 5 indexed citations
10.
Celma, A., Ruth López, S. Roche, et al.. (2019). Las biopsias de próstata dirigidas ¿están listas para reemplazar las biopsias de próstata sistemáticas?. Actas Urológicas Españolas. 43(10). 573–578. 2 indexed citations
11.
Regis, Lucas, Albert Salazar, S. Roche, et al.. (2018). La resonancia magnética preoperatoria predice la recuperación temprana de la continencia urinaria tras la prostatectomía radical robótica. Actas Urológicas Españolas. 43(3). 137–142. 10 indexed citations
12.
Moróte, Juan, A. Celma, S. Roche, et al.. (2018). Who Benefits from Multiparametric Magnetic Resonance Imaging After Suspicion of Prostate Cancer?. European Urology Oncology. 2(6). 664–669. 21 indexed citations
13.
14.
Payán, Andrey, F. Sztark, Vincent Piriou, et al.. (2013). Évaluation du Risque CARDiaque de l’Opéré (RICARDO) : enquête nationale auprès des anesthésistes-réanimateurs concernant la prise en charge périopératoire du patient à risque cardiaque. Annales Françaises d Anesthésie et de Réanimation. 32(10). 676–683. 4 indexed citations
15.
Pineda, Víctor, et al.. (2012). Unilateral Pulmonary Artery Agenesis, Angio-MR Findings. Revista Española de Cardiología (English Edition). 66(10). 821–821. 1 indexed citations
16.
Puybasset, Louis, Jean‐Jacques Rouby, E. Mourgeon, et al.. (1995). Factors Influencing Cardiopulmonary Effects of Inhaled Nitric Oxide in Acute Respiratory Failure. American Journal of Respiratory and Critical Care Medicine. 152(1). 318–328. 117 indexed citations
17.
Law-Koune, J.D., S. Roche, E. Mourgeon, et al.. (1994). ACUTE TOXICITY OF INHALED NITRIC OXIDE IN PATIENTS WITH ACUTE RESPIRATORY DISTRESS SYNDROME. Anesthesiology. 81(SUPPLEMENT). A264–A264.
18.
Roche, S., et al.. (1990). Cutaneous myiasis in an elderly debilitated patient. Postgraduate Medical Journal. 66(779). 776–777. 9 indexed citations
19.
Thompson, Alan J., C. Kennard, Michael Swash, et al.. (1989). Relative efficacy of intravenous methylprednisolone and ACTH in the treatment of acute relapse in MS. Neurology. 39(7). 969–969. 93 indexed citations
20.
Bridges, Leslie, S. Roche, Lina Nashef, & F. Clifford Rose. (1988). Haemangiopericytic meningioma of the sacral canal: a case report.. Journal of Neurology Neurosurgery & Psychiatry. 51(2). 288–290. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaoye Lu Breakdown of academic impact, for papers by H. Erhan Dincer Breakdown of academic impact, for papers by Hideyuki Maeda Breakdown of academic impact, for papers by Stanley J. Antolak Breakdown of academic impact, for papers by Takahiro Maeda Breakdown of academic impact, for papers by Munir Nashashibi Breakdown of academic impact, for papers by Daniel Char Breakdown of academic impact, for papers by Shaan Chugh Breakdown of academic impact, for papers by Domenico Mancuso Breakdown of academic impact, for papers by Pierre Filhine-Trésarrieu
Rankless by CCL
2026